# A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults

> **NCT05901636** · PHASE1,PHASE2 · COMPLETED · sponsor: **Janssen Vaccines & Prevention B.V.** · enrollment: 170 (actual)

## Conditions studied

- Influenza Prevention

## Interventions

- **BIOLOGICAL:** INFLUENZA G1 mHA
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** Al(OH)3

## Key facts

- **NCT ID:** NCT05901636
- **Lead sponsor:** Janssen Vaccines & Prevention B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-17
- **Primary completion:** 2024-08-19
- **Final completion:** 2024-08-19
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05901636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05901636, "A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05901636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*